Profluent's New CRISPR Approach Expands Targetable Mutations by 10X
nathanbenaich · x · 2026-08-04
AI biotech company Profluent has announced a breakthrough in CRISPR technology. Their new approach enables 10X the number of targetable mutations for base editing. This significantly expands the addressable market and potential patient populations for gene editing therapies.
More from Research
- Biomni Lab Partners with Chugai to Deploy AI Drug Discovery Platform — KexinHuang5 · 2026-08-05
- Proposing 'Latent Reading': Exploring Literature via Single-Text AI Models — begusgasper · 2026-08-04
- Practical Alignment Agenda: Eradicating Reward Hacking and Model Deception — MariusHobbhahn · 2026-08-04
- Why LLMs Corrupt Your Notes and How to Fix It Structurally — Cryvixx · 2026-08-04
- Frontier VLMs Fail at Jigsaw Puzzles: JigShape Benchmark Tests Geometric Reasoning — _vztu · 2026-08-04
- An Ethical Alternative to the Controversial Lena Test Image — ssh4net · 2026-08-04